Transaction · 0001780660-26-000022
ADPTAdaptive Biotechnologies Corp
Lo Francis
LO FRANCIS, CPO, reported a transaction classified as exercise at Adaptive Biotechnologies Corp involving 53091.000000 shares for an estimated $0.00. Reported holdings after the transaction were 79155.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MCPO
- Trade date
- Sep 16, 2026
- Filing date
- Sep 19, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ADPT price since this filing
Daily closing prices, with the filing date and available return windowsADPT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -13.4%1w ago -14.6%1d ago -6.7%
Returns since7d +2.9%30d -16.0%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001780660-26-000022 Stock Option (right to buy)
- Transaction date
- Sep 16, 2026 Filed Sep 19, 2026, 12:17 AM · 3d delay
- Shares
- 53,091 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 79,155 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
Low filing signal
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief People Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
- F2
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.49 to $28.48, inclusive. The reporting person undertakes…
- F3
The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.49 to $28.67, inclusive. The reporting person undertakes…
- F4
The option is fully vested and exercisable.
- F5
The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
- F6
The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
- F7
The options vested with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Related transactions
Same SEC filing0 other transactions
Recent company activity
ADPT0 recent txs